Skip to content
Contact Us
0
IDKmonitor Infliximab TOTAL anti-drug antibody assay
Back To Our Shop

Infliximab Total Anti-drug Antibody ELISA (IDKmonitor®)

Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Infliximab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.

Category:

Key Advantages

Supports the investigation of primary non-response and loss of response to infliximab

Highly sensitive drug tolerant assay that detects total anti-infliximab antibodies (those free and bound to infliximab)

May help to predict long term outcome of disease

Identifies patients with low-titre anti-infliximab antibodies

Applicable to both gastroenterology and rheumatology

Automatable on ELISA automates (e.g. Dynex DS2)

Determination of total anti-infliximab antibodies

Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Infliximab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.

The assay is widely available throughout the UK and Ireland to both routine clinical laboratories as well as for research applications. Please contact us for your nearest test reference laboratory. This kit is supported by UK publications and evidence base.

  • ELISA

  • 45 tests

  • Storage: 2-8 °C

  • Blood sample